Robert Hofmeister - 30 Mar 2023 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
30 Mar 2023
Net transactions value
$0
Form type
4
Filing time
19 Apr 2023, 17:00:09 UTC
Previous filing
10 Dec 2021
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 30 Mar 2023 Common Stock 150,000 $0.6600 Direct F1
transaction TCRT Employee Stock Option (right to buy) Award $0 +16,667 $0.000000 16,667 30 Mar 2023 Common Stock 16,667 $0.6600 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from March 30, 2023, with the first vesting occuring on April 30, 2023, subject to the Reporting Person's continued service through each such date.
F2 In equal installments on April 30, 2023 and May 30, 2023, subject to the Reporting Person's continued service through each such date.